Introduction 96 97
The AFF1 (AF4/FMR2 family member 1, a.k.a AF4), AFF2 (a.k.a FMR2), AFF3 (a.k.a 98 LAF4) and AFF4 genes encode members of the ALF (AF4/LAF4/FMR2) family. These 99 transcription factors share five highly conserved domains starting from the amino terminus: 100 (i) an N-terminal homology domain (NHD); (ii) the hallmark ALF domain, which interacts 101 with Seven In Absentia Homolog (SIAH) ubiquitin ligases through the [xPxAxVxPx] degron 102 motif 1,2 and thus regulates protein degradation mediated by the proteasome pathway; (iii) a 103 serine-rich transactivation domain 3 ; (iv) a bipartite nuclear localization sequence (NLS); and 104
(v) a C-terminal homology domain (CHD) 4,5 . AFF1, AFF3, and AFF4 have each been 105 identified as fusion partners of the mixed-lineage leukemia (MLL) gene involved in acute 106 pediatric leukemias 3 . They are part of the super elongation complex 6 implicated in 107 transcription of a set of genes, among them histones, retinoid signaling and HOX genes 108 involved in neurogenesis and several other developmental processes (e.g. Hoxa1, Cdx11 and 109 Cyp26a1 6,7 ). Mutations of the fruit fly ALF orthologous gene lilliputian (lilli) were shown to 110 prevent neuronal differentiation and to decrease cell growth and size 8, 9 . Silencing of AFF2 by 111 CGG repeat expansion is associated with FRAXE intellectual disability syndrome 10 (OMIM 112 #309548), whereas hypermethylation of a mosaic CGG repeat expansion in the promoter of 113 AFF3, which leads to its silencing in the central nervous system, was associated with a 114 cytogenetic fragile site (FRA2A) and intellectual disability in three families 11 . AFF3 is also 115 known for regulating the expression of imprinted genes 12,13 such as XIST through binding to 116 differentially methylated regions 14 . An individual carrying a 500kb microdeletion within the 117 AFF3 locus and presenting with skeletal dysplasia and encephalopathy was described 15 . 118 119 Six de novo missense variants in AFF4 were recently linked with CHOPS (Cognitive 120 impairment and coarse facies, Heart defects, Obesity, Pulmonary problems, Short stature and 121 skeletal dysplasia) syndrome 16,17 (OMIM#616368). They were suggested to act through 122 reduced clearance of AFF4 by SIAH, a hypothesis supported by the fact that surviving adult 123
Aff4 null mice have only azoospermia and no features of CHOPS syndrome. However, a 124 majority of Aff4 -/embryos died in utero with severely shrunken alveoli of the lung 18 . 125
Upregulation of AFF4 resulted in dysregulation of genes involved in skeletal development 126 and anterior/posterior pattern formation such as MYC, JUN, TMEM100, ZNF711 and 127 FAM13C 16 . These molecular changes were proposed to impair complex function and lead to 128 Proband 3: The exomes of proband 3, his parents and two healthy siblings were captured and 162 sequenced as described 21 . Variants were called and filtered using the Varapp software 22 . 163 Sanger sequencing confirmed the anticipated segregation of the potentially causative variants. 164
Proband 4: Exome capture and sequencing was performed as previously described 19 . 165
Proband 5: Exome sequencing of the proband was performed as previously described 23 . 166
Sanger sequencing of samples from parents revealed de novo segregation of the variant. 167
Proband 6: Trio genome analysis was performed as previously described 24 . Sanger 168 sequencing confirmed the de novo variant reported here. 169
Proband 7: Trio exome analysis was performed as previously described 25 
Zebrafish overexpression model 207
Human wild-type ORFs (AFF3, NM_002285.2 and AFF4, NM_014423.4) cloned into the 208 pEZ-M13 vector were transcribed using the mMessage mMachine kit (Ambion) as prescribed. 209
We injected 1-2 nL of diluted RNA (100-300 ng) inside the yolk, below the cell of wild-type 210 zebrafish embryos at the 1-to 2-cell stage. Phenol red dye with distilled water was injected as 211 vehicle control in similar volume. Injected embryos were raised at 28°C and fixed in 4% PFA 212 for 2 hrs at 4-5 days post fertilization (dpf) and stored in PBS at 4°C. Pictures of the embryos 213 were taken after embedding in glycerol. Counts were compared by Fisher exact test. 214
215

Protein accumulation assay 216
Tagged human wild-type mRNAs cloned into a CMV promoted expression vector were 217 obtained from GeneCopoeia. The ORFs of AFF3 and AFF4 were inserted in pEZ-M13 vector 218 with a C-terminal FLAG tag, while the ORF of SIAH1 (NM_001006610) was inserted in 219 pEZ-M07 vector with a C-terminal 3xHA tag. The AFF3 NM_002285.2:c.697G>A, 220 c.704T>G, and AFF4 NM_014423.4:c.772C>T mutations were engineered using the 221 QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies) following the 222 manufacturer's instructions. HEK293T cells cultured in complete medium (DMEM 223 containing 10% FBS and 1% penicillin-streptomycin) were transiently transfected with wild 224 type and mutated plasmids using calcium phosphate. 24 hrs after transfection, medium was 225 changed to fresh complete medium. Total protein extracts were obtained after 48 hrs using 226 RIPA buffer with protease and phosphatase inhibitor cocktail. Denatured protein extracts 227 were immunoblotted with anti-FLAG (F3165), -HA (12CA5) and -β-actin (A2066) antibodies 228 from Sigma-Aldrich. 229
Results 231
232
We identified ten unrelated affected individuals (probands 1-10) with de novo missense 233 variants in the ALF domain of AFF3 ( Figure 1A Table 1 ). An eleventh 243 individual (deletion proband) carrying a 500kb microdeletion and an overlapping phenotype 244 (see below) was previously described 15 . This deletion removes exons 4 to 13 of AFF3, which 245 encode its N-terminal region, including the ALF and its degron and part of the transactivation 246 domains and was proposed to act as a dominant negative 35 (Figure 1A) . 247 248 All AFF3 variants described here and CHOPS syndrome-associated AFF4 de novo missense 249 previously published 16,17 map within the degron motif of the ALF domain. This highly 250 conserved 9 amino acid sequence [xPxAxVxPx] (Figure 1A-B ) mediates interaction with the 251 SIAH E3 ubiquitin ligase and regulates their degradation 1 . According to pathogenic variant 252 enriched regions (PER) 43 , the degron is predicted to be constrained within the ALF family. 253
Pathogenicity of the four de novo AFF3 identified variants is further supported by the three-254 dimensional representation of part of the encoded peptide ( Figure 1D) . The mutated residues 255 are located within the degron motif (KPTA258YV260RPM), which adopts a beta-strand 256 conformation directly contacting the SIAH ubiquitin ligase binding groove 30 We compared the phenotypes of the ten individuals with de novo variants in AFF3 described 270 here and that of the previously reported case carrying AFF3 partial deletion 15 (Table S1 for 271 detailed phenotypes). They exhibit severe developmental epileptic encephalopathy (10 272 probands out of 11), along with mesomelic dysplasia resembling Nievergelt/Savarirayan 273 mesomelic skeletal dysplasia (NSMSD) (10/11) and failure to thrive (10/11). These three 274 features are often associated with microcephaly (7/11), global brain atrophy and/or 275 ventriculomegaly (7/9) (Figure S1), fibular hypoplasia (9/11), horseshoe kidney (8/11), 276 abnormalities of muscle tone (9/10), gastroesophageal reflux disease (5/10) and other 277 gastrointestinal symptoms (10/10). They also share common dysmorphic facial features such 278 as a bulbous nasal tip (6/9), a wide mouth with square upper lip (7/10), abnormalities of the 279 teeth and gums (9/10) and hypertrichosis (8/9) (Figure 2-3) . Respiratory 280 difficulties/pulmonary involvement were observed in about half of the probands with de novo 281 variants (6/11). Whereas respiratory arrest led to the death of proband 3 at 21 years, the 282 deletion proband died at four months after recurrent apneic episodes (Table S1) . 283 284 This constellation of features recalls some features of CHOPS-affected individuals. The three 285 originally described probands 16 , along with the eight recently identified 17 , presented with 286 distinctive facial dysmorphic features reminiscent of CdLS, short stature with obesity (11/11), 287 developmental delay/intellectual disability (DD/ID) (11/11) and microcephaly (6/11) without 288 epilepsy. They showed gastrointestinal abnormalities (8/11), accompanied by abnormal 289 feeding behavior (6/6), hearing loss (8/11), cardiac (8/11) and pulmonary defects (8/11) and 290 rarely horseshoe kidney (2/11). Whereas they present with vertebral abnormalities (5/11) and 291 brachydactyly (8/11), mesomelic dysplasia is never observed and hypoplastic fibula rarely 292
(1/11). 293 294 Although phenotypes of AFF3 and AFF4 missense carriers are overlapping, they are not 295 identical. We thus suggest naming the distinct autosomal dominant AFF3-associated disorder 296 KINSSHIP syndrome (KIdney anomalies, Nievergelt/Savarirayan mesomelic dysplasia, 297
Seizures, Hypertrichosis and Intellectual disability with Pulmonary involvement, MIM 298 #XXXX) to evoke both some of its cardinal characteristics, as well as its similarity (common 299 mode of action and inheritance and overlapping phenotypes) with CHOPS syndrome. 300
301
To better understand the functional effects of AFF3 variation, we investigated both knock-out 302 and knock-in mouse models ( Table 2) . We first studied the knock-out mouse line engineered 303 by the International Mouse Phenotyping Consortium 33 (IMPC). The IMPC routinely measures 304 an extensive series of parameters and evaluate if those are significantly different from wild-305 type mice 44 (p≤10 -04 ). Aff3 +/and Aff3 -/mice exhibit skeletal defects including fusion of 306 vertebral arches, vertebral transformation and decreased caudal vertebrae number. 307
Homozygous knock-out mice also show an abnormal skull shape with a small, deviated snout 308 and malocclusion as well as decreased serum fructosamine and albumin levels that could 309 reflect kidney defects and/or metabolic dysregulation. Neurological dysfunctions were also 310 noted with an increased or absent threshold for auditory brainstem response (signs of hearing 311 impairment) and diminished grip strength. As Aff3 is expressed in progenitor neurons 45 and 312 required for neuronal migration in the cerebral cortex 46 , we further assessed the consequences 313 of Aff3 disruption on brain development by measuring a standardized set of 78 parameters 314 across 22 brain regions 34 . Compared with wild type males, homozygous Aff3 -/-, but not 315 heterozygous Aff3 +/males, exhibited significantly enlarged lateral ventricles (p = 1.24 x 10 -316 04 ) and decreased corpus callosum size (p = 3.02 x 10 -06 ; Figure 4) , similar to the phenotypes 317 observed in proband 2, 3 and 6 and in the previously reported deletion proband (Table S1 , 318 Figure S1) 15 . These features are in stark contrast with results obtained with another 319 engineered Aff3 -/line that showed no phenotypic perturbations possibly because of genetic 320 background differences, i.e. C57BL/6N versus CD1, and/or focusing on limb morphology 321 only 35 . 322
323
We then reassessed mouse models mimicking the deletion identified in the previously 324 described proband, which were previously engineered to assess an aggregation method for the 325 rapid generation of structural variants 35 . Consistent with the phenotype of the deletion 326 proband, homozygous animals chimeric for a 353kb deletion syntenic to the 500kb human 327 deletion exhibited mesomelic dysplasia, triangular tibia, severe hypoplastic fibula and 328 polydactyly of the feet 35 ( Table 2) . Reexamination of these Aff3 del/del (a.k.a. Laf4 del/del ) mice 329 showed that they also presented with reduced body size, craniofacial dysmorphisms with 330 delayed ossification of skull bones, hypoplastic pelvis, intestinal prolapse and neurological 331 dysfunction (Figure 5A-C) . Chimeric Aff3 del/+ heterozygotes presented with variable features 332 ranging from unaffected to homozygous deletion-like phenotypes. Whereas Aff3 del/+ animals 333 with low chimerism were fertile they produced no heterozygous offspring suggesting lethality 334 of the 353kb deletion ( Table 2) . While these results support a causative role for the deletion 335 in the deletion proband, they do not allow differentiating between gain-of-function and 336 haploinsufficiency. 337
338
To further assess the underlying mutational mechanism in our missense probands, we 339 engineered a knock-in mouse model carrying the Aff3 A233T mutation that is the equivalent of 340 the most commonly observed de novo variant, identified in probands 3 to 8 [p.(A258T)]. The 341 microinjection of a total of 410 C57BL/6NTac zygotes and transfers into 14 recipient females 342 to allow CRISPR/Cas9 editing resulted in only 13 pups at weaning. Genotyping showed that 343 most of them were either wild type (8 individuals) or carried CRISPR/Cas9-mediated 344 mutations (4) although reduced gRNA activity was used for microinjection. A single female 345 F0 founder animal showed the targeted A233T knock-in but with a very low mosaicism rate 346 of 16.7% in an ear biopsy. Genotyping showed that none of its offspring from four 347 consecutive pregnancies were heterozygous for the mutation. These results suggest that the 348 Aff3 A233T mutation is lethal with high mosaicism (homozygous Aff3 A233T/A233T and 349 heterozygous Aff3 +/A233T chimeras), in gametes or during the fetal period (heterozygous 350 Aff3 +/A233T ; Table 2 ). The success statistics of similar CRISPR/Cas9 knock-in projects 351 performed by Taconic Biosciences GmbH (Cologne, Germany) through the years further 352 support this hypothesis. Out of 92 attempted knock-in constructs 98% were successful with 353 only 2% failing to generate F0 animals. For most projects, positive F1 animals were also 354 generated. 355
356
To lend further support to the model centered on a pathological increase of AFF3 protein 357 product in affected individuals, we assessed its accumulation in zebrafish. Whereas the 358 genome of these teleosts encodes four ALF transcription factors orthologous to the 359 mammalian AFF1 to AFF4, these genes do not harbor a [xPxAxVxPx] degron motif 360 suggesting that their degradation is regulated differently in fish. Therefore, we modeled 361 accumulation by independently overexpressing increasing amounts of unmutated human 362 AFF3 and AFF4 mRNA in zebrafish embryos. We observed a dose-dependent increase in the 363 fraction of 4 dpf embryos with morphological defects upon overexpression of AFF3. The 364 observed phenotypes included bent body axis, yolk sac edema and generalized body 365 development defects at higher doses (Figure 5D-E) . A similar albeit less pronounced dose-366 dependent increase in zebrafish embryos with morphological defects was seen upon 367 overexpression of AFF4 (Figure 5E) . 368
369
To further assess the redundancy of ALF transcription factors, we took advantage of 370 published knockdown experiments 47 . Luo and colleagues established and profiled the 371 transcriptome of stable HEK293T cell lines independently knocked down for AFF2, AFF3 372 and AFF4 expression by specific shRNAs. Reanalysis of these data confirmed that ALF 373 transcription factors have mostly different target genes, as 55% (125 out of 226), 62% 374 (261/423) and 87% (966/1116) of the genes are specifically perturbed by the knock down of 375 AFF2, AFF3 and AFF4, respectively (Figure 6A) . Intriguingly, the subset of common targets 376 is similarly influenced by decreased expression of AFF2 and AFF3 (Figure 6C,D) , whereas 377 knocking down AFF3 and AFF4 had opposite effect (Figure 6B as the erratic menstrual cycle of proband 4 (most probands being too young to predict any 389 pubertal anomaly) and popliteal pterygium in proband 8 (Table S1) . 390 391 Discussion 392
All eleven individuals with an AFF3 variant we identified have a complex but overlapping 393 clinical presentation, which we named KINSSHIP syndrome. One of the cardinal 394 characteristics of this rare autosomal dominant syndrome is mesomelic dysplasia with short 395 forearms, radial head dislocation/subluxation, triangular and/or short tibia, fibular hemimelia, 396 hip dislocation, tarsal and/or metatarsal synostosis resembling NSMSD (Figure 3) . NSMSD 397 is a sporadic or rare autosomal dominant condition 48,49 associated with neurodevelopmental 398 and often urogenital abnormalities 50,51 . KINSSHIP affected individuals similarly present with 399 vertebral and bone mineralization defects, scoliosis, epilepsy, severe global DD/ID sometimes 400 associated with structural brain abnormalities, significant feeding difficulties, horseshoe 401 kidney, hypertrichosis and recognizable facial features. Multiple probands showed coarsening 402 facial features with age, including a large nose with bulbous nasal tip, a prominent columella 403 and a wide mouth with square upper lip (Figure 2-3, Table S1, Figure S1) . While widespread hypertrichosis may have been partially caused by multi-drug, antiepileptic 416 treatment in probands 3 and 4, its presence in the only non-epileptic AFF3 individual 417 (proband 9) and the much younger proband 5 seems to confirm the association of this feature 418 with AFF3 genetic variants. It is possible that the complex clinical presentation of the cases 419 described here (Table S1) We thank the probands and their families for their participation in this study. We are grateful 474 to Jacques S. Beckmann, Giedre Grigelioniene and the Genomic Technologies only side-chains of the core degron motif (P256, A258, V260 and P262) are shown, with 718 yellow highlights on the KINSSHIP mutated residues. A zoom in is displayed on the right. 719
The core degron motif adopts a beta-strand conformation directly contacting the ubiquitin 720 ligase-binding groove. The sidechains of A258 and V260 are embedded into binding pockets 721 too small to accommodate larger side chains 32 . They are in direct proximity of Siah residues 722 T156 (pink) and M180 (cyan), identified as key binding residues in a series of pull-down 723 assays 32 . The longer side-chains of A258T, A258S, A258V variants and the smaller V260G 724 are likely to weaken or prevent the interaction with the ligase. 725 
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